Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

World Class Technology Corp. is a private company headquartered in McMinnville, OR, that supplies dental equipment. The firm was founded in 1963 by Klaus Hagelganz, he has been the CEO since then.

Dentaurum GmbH & Co. KG is a German private company located in Ispringen. The firm provides dental services. It was founded in 1886 by Arnold Biber. Mark S. Pace and Axel Winkelstroeter are the current co-CEOs of the firm.\nAn excerpt from the company's website reads as follows: Over the last century and a quarter Dentaurum has grown from a simple dental laboratory to a dental company with operations worldwide. The secret of our success is close contact with our customers and our interest in innovations that lead to the development of new products. As an owner-managed family company in the fourth generation we are independent and flexible and we are in a position to respond quickly in a focused manner to market changes. This establishes a secure base for the future success of the Dentaurum Group. We are continuously investing in new technology and optimising our processes to economise on valuable resources.

Guangzhou Mingyi Electronic Machinery Co., Ltd., established on 1999-02-03, Business scope includes mold manufacturing;Manufacturing of special equipment for electrical machinery;Manufacturing of special equipment for the electronics industry;Safety Production Technical Services;Power Electronics Technical Services;General Machinery Sales;Sales of electrical machinery and equipment;Manufacturing of electronic components and assemblies;Wholesale of chemical products(Excluding hazardous chemicals);Commodity wholesale trade(Except for commodities involving special management regulations on foreign investment access and licensing approval);Commodity retail trade(Except for commodities involving special management regulations on foreign investment access and licensing approval);

Calliditas Therapeutics France SAS is a biopharmaceutical company that develops NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The company's platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes. The company's product candidate, setanaxib, a NOX1 and NOX4 inhibitor, demonstrated clinical evidence of anti-fibrotic activity in liver fibrosis patients in a phase II trial in primary biliary cholangitis. Genkyotex was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France.

Henkel AG & Co. KGaA engages in the production, sale, and distribution of home and beauty care products. The firm also provides adhesive technology solutions. It operates through the Adhesive Technologies and Consumer Brands segments. The Adhesive Technologies segment sells adhesives, sealants, and functional coatings for consumers, craftsmen, and industrial applications. The Consumer Brands segment offers branded products for consumers and professional applications for the hairdressing business that includes products for hair care, styling and coloring, as well as detergents and fabric softeners. The company was founded by Fritz Henkel on September 26, 1876 and is headquartered in Dusseldorf, Germany.

Regus Services Ltd. is a private company headquartered in Hong Kong, Hong Kong. The firm provides office machinery and equipment leasing services.

Beijing Taisheng Biotechnology Co., Ltd., established on 2014-03-06, Business scope includes general items:Medical Research and Experimental Development;Human stem cell technology development and application;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engage in investment activities with own funds;hospital management;Health Consulting Services(Does not include medical services);Cosmetics Wholesale;Cosmetics Retail;Daily necessities sales;Sales of Class II Medical Devices;Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Cosmetic production;pharmaceutical production;Class III medical device business;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Natural Implant SA develops and manufactures dental implants from biomaterial. The company manufactures a novel type of dental implant made from an FDA biomaterial around which it grows periodontal ligament cells using tissue engineering techniques. Natural Implant was founded in 1998 and is headquartered in Brest, France.

SmileSonica Inc. is a Canadian company founded on the principle of making ideas and concepts widely available to benefit the world. As their company evolved, they applied their knowledge, experience, and commitment to pursue the unknown, meet new challenges, and be their best as a team. The SmileSonica team designs, develops, manufactures, and commercializes medical devices, advanced materials, and instrumentation for both medical and non-medical applications in Canada and throughout the world.